Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy.
Gupta
Ankur
A
Department of Nephrology, All India Institute of Medical Sciences, New Delhi, 110029, India. parthankur@yahoo.com.|, BD-10, Vishakha enclave, Pitampura, New Delhi, 110088, India. parthankur@yahoo.com.
Khaira
Ambar
A
Department of Nephrology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Singh
Bakshish
B
Department of Nephrology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Bhowmik
Dipankar M
DM
Department of Nephrology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Tiwari
Suresh C
SC
Department of Nephrology, All India Institute of Medical Sciences, New Delhi, 110029, India.
D000328:Adult; D000577:Amides / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D005650:Fumarates / Q000627:therapeutic use*; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000188:drug therapy* / Q000473:pathology; D012084:Renin-Angiotensin System / Q000187:drug effects*; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D000577:Amides; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D005650:Fumarates; C446481:aliskiren